JW Pharmaceutical Corporation (KRX: 001060)

JW Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	704,465	828,523	419,688	505,678	753,056	616,431
Market Cap Growth	32.35%	97.41%	-17.00%	-32.85%	22.16%	-24.74%
Enterprise Value	746,575	959,912	491,395	649,827	873,041	765,409
Last Close Price	28450.00	35550.00	17792.57	21052.34	30980.57	25161.32
PE Ratio	19.05	22.74	12.96	-504.81	-47.20	-23.11
PS Ratio	0.89	1.11	0.61	0.83	1.38	1.21
PB Ratio	2.47	3.12	1.86	2.68	3.63	2.68
P/FCF Ratio	6.60	13.84	8.96	47.45	14.86	13.33
P/OCF Ratio	5.87	9.51	7.39	27.90	11.94	11.10
EV/Sales Ratio	1.01	1.28	0.72	1.07	1.60	1.50
EV/EBITDA Ratio	6.50	8.05	6.35	13.84	45.08	573.24
EV/EBIT Ratio	7.82	9.93	8.12	21.07	-659.90	-40.26
EV/FCF Ratio	7.05	16.03	10.49	60.98	17.23	16.55
Debt / Equity Ratio	0.53	0.64	0.93	1.30	0.88	0.82
Debt / EBITDA Ratio	1.33	1.43	2.71	5.22	9.41	140.45
Debt / FCF Ratio	1.41	2.84	4.47	23.00	3.60	4.05
Asset Turnover	1.13	1.18	1.09	1.03	0.98	0.88
Inventory Turnover	3.59	3.79	3.70	3.65	3.86	3.65
Quick Ratio	0.93	0.90	0.80	0.79	0.78	0.81
Current Ratio	1.34	1.32	1.12	1.30	1.28	1.21
Return on Equity (ROE)	13.06%	15.65%	14.41%	-0.73%	-6.98%	-10.31%
Return on Assets (ROA)	8.88%	9.49%	6.00%	3.26%	-0.15%	-2.04%
Return on Capital (ROIC)	12.65%	13.87%	8.70%	4.68%	-0.20%	-2.70%
Earnings Yield	5.25%	4.47%	7.60%	-0.19%	-2.02%	-4.10%
FCF Yield	15.14%	7.23%	11.16%	2.11%	6.73%	7.50%
Dividend Yield	1.41%	1.10%	-	-	-	-
Payout Ratio	27.11%	23.82%	23.05%	-	-	-
Buyback Yield / Dilution	-0.14%	-0.48%	-0.08%	0.05%	-0.04%	13.15%
Total Shareholder Return	1.27%	0.62%	-0.08%	0.05%	-0.04%	13.15%

Source: S&P Capital IQ. Standard template. Financial Sources.